Market Value1,235,544,487
Total Holdings57
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CLDX / Celldex Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
VTYX / Ventyx Biosciences, Inc.
ELEV / Elevation Oncology, Inc.
XENE / Xenon Pharmaceuticals Inc.
TRML / Tourmaline Bio, Inc.
GERN / Geron Corporation
ATXS / Astria Therapeutics, Inc.
LPTX / Leap Therapeutics, Inc.
OCUL / Ocular Therapeutix, Inc.
DSGN / Design Therapeutics, Inc.
ATXS / Astria Therapeutics, Inc. Call
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
IMVT / Immunovant, Inc.
JANX / Janux Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
BOLD / Boundless Bio, Inc.
KYTX / Kyverna Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc. Call
PRAX / Praxis Precision Medicines, Inc.
ALLK / Allakos Inc.
RVMD / Revolution Medicines, Inc.
EWTX / Edgewise Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
ATYR / aTyr Pharma, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
CGEM / Cullinan Therapeutics, Inc.
IMUX / Immunic, Inc.
KURA / Kura Oncology, Inc.
IOBT / IO Biotech, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
FULC / Fulcrum Therapeutics, Inc. Call
ENGN / enGene Holdings Inc.
APLT / Applied Therapeutics, Inc.
CGON / CG Oncology, Inc.
NMRA / Neumora Therapeutics, Inc.
IMTX / Immatics N.V.
KNSA / Kiniksa Pharmaceuticals, Ltd.
ARGX / argenx SE - Depositary Receipt (Common Stock)
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
SLRN / Acelyrin, Inc.
KRTX / Karuna Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc. Call
ICVX / Icosavax, Inc.
RCUS / Arcus Biosciences, Inc.
RYZB / RayzeBio, Inc.
RPTX / Repare Therapeutics Inc.
MORF / Morphic Holding, Inc.
AMAM / Ambrx Biopharma Inc.
INBX / Inhibrx Biosciences, Inc. Call
DCTH / Delcath Systems, Inc.
MLTX / MoonLake Immunotherapeutics
INBX / Inhibrx Biosciences, Inc.
SRPT / Sarepta Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc. Call
MOR / MorphoSys AG - Depositary Receipt (Common Stock) Call
SYRE / Spyre Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
OLMA / Olema Pharmaceuticals, Inc.
ADVM / Adverum Biotechnologies, Inc.
CYBN / Cybin Inc.
LRMR / Larimar Therapeutics, Inc. Call
XNCR / Xencor, Inc.
DYN / Dyne Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
AKRO / Akero Therapeutics, Inc.
VERA / Vera Therapeutics, Inc.
NXTC / NextCure, Inc.
TRVI / Trevi Therapeutics, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
LCTX / Lineage Cell Therapeutics, Inc.
ANNX / Annexon, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
ELVN / Enliven Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) Call
ALNY / Alnylam Pharmaceuticals, Inc. Call
APLS / Apellis Pharmaceuticals, Inc.
UNCY / Unicycive Therapeutics, Inc.
ANNX / Annexon, Inc. Call
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc. Call